A novel nanobody targeting the inflammatory IL-17 pathway has shown remarkable efficacy in patients with active Psoriatic Arthritis (PsA).
Most Recent Articles
Two-in-One Protection: Evaluating the Trivalent Salmonella Polysaccharide Conjugate Vaccine
A new study evaluating a Trivalent Salmonella Conjugate Vaccine (TSCV) confirms its safety and reports 100% immunogenicity against key antigens, offering a promising solution to highly prevalent invasive disease in young children.
Delayed Diagnosis and Greater Disability: The Impact of ADHD on Adult Females
A new study evaluating sex differences in adult Attention-Deficit/Hyperactivity Disorder (ADHD) confirms that females are diagnosed significantly later than males and experience greater severity, depression, anxiety, and overall...
RZV Shows High, Consistent Protection for Immunocompromised and Immunocompetent Seniors
A new study evaluating the recombinant herpes zoster vaccine (RZV) in the Medicare population confirms its high effectiveness across both immunocompetent and immunocompromised older adults.
Generative AI for Healthcare: Real-Time Physiological State Interpretation via HRV
Explore a novel pipeline connecting real-time heart rate variability data from wearable sensors directly to generative AI for enhanced physiological state interpretation and adaptive LLM interactions.